Precision medicine involves understanding the molecular drivers unique to an individual patient's cancer so that specific factors may be targeted with the goal of improved patient outcomes. The purpose of this article is to review standard of care and research grade (non-standard of care) biomarkers in breast cancer that may be useful for diagnosis, prognosis and targeted therapy.
Keywords: biomarker; breast cancer; molecular marker; personalized medicine; precision medicine.
© 2014 Wiley Periodicals, Inc.